Legend Biotech (LEGN) Change in Inventory (2020 - 2025)
Legend Biotech (LEGN) reported Change in Inventory of $5.4 million for Q3 2025, up 205.75% on a YoY basis from $1.8 million in Q3 2024, and up 292.72% quarter-over-quarter from -$2.8 million in Q2 2025.
Legend Biotech (LEGN) Change in Inventory (2020 - 2025) Analysis & Trends
Legend Biotech has reported Change in Inventory for 6 years, with the latest figure at $5.4 million in Q3 2025.
- For the quarter ending Q3 2025, Change in Inventory rose 205.75% year-over-year to $5.4 million; the trailing twelve-month figure through Sep 2025 stood at -$6.9 million (up 52.8% YoY), and the FY2024 full-year result was -$17.2 million, down 35.43% from the prior year.
- Change in Inventory for Q3 2025 stood at $5.4 million, up from -$2.8 million in the prior quarter.
- The five-year high for Change in Inventory was $5.4 million in Q3 2025, with the low at -$8.6 million in Q4 2022.
- Historically, Change in Inventory has averaged -$2.5 million across 5 years, with a median of -$2.8 million in 2025.
- Annual changes were most pronounced in 2022 — Change in Inventory slumped 7382.61% — and 2025, when it surged 205.75%.
- Legend Biotech's Change in Inventory stood at -$115000.0 in 2021, then tumbled by 7382.61% to -$8.6 million in 2022, then soared by 56.98% to -$3.7 million in 2023, then tumbled by 69.23% to -$6.3 million in 2024, then soared by 185.76% to $5.4 million in 2025.
- The last three Change in Inventory figures came in at $5.4 million (Q3 2025), -$2.8 million (Q2 2025), and -$3.2 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -26.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.37 Mn |
| Sep 30, 2025 | 5.37 Mn |
| Jun 30, 2025 | -2.79 Mn |
| Jun 30, 2025 | -2.79 Mn |
| Mar 31, 2025 | -3.23 Mn |
| Mar 31, 2025 | -3.23 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Sep 30, 2024 | -5.08 Mn |
| Sep 30, 2024 | -5.08 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Mar 31, 2024 | -4.47 Mn |
| Mar 31, 2024 | -4.47 Mn |
| Dec 31, 2023 | -3.70 Mn |
| Dec 31, 2023 | -3.70 Mn |
| Sep 30, 2023 | -3.59 Mn |
| Sep 30, 2023 | -3.59 Mn |
| Jun 30, 2023 | -3.25 Mn |
| Jun 30, 2023 | -3.25 Mn |